<?xml version="1.0" encoding="UTF-8"?>
<p id="p0090">In addition to CEPI, the WHO and the U.S. National Institutes of Health (NIH) are contributing to global collaborative efforts to accelerate vaccine development. The WHO Solidarity Trial for vaccines is a large, multi-site individually randomised controlled clinical trial to allow evaluation of the benefits and risks of each COVID-19 candidate vaccines within 3â€“6 months 
 <xref rid="b0400" ref-type="bibr">[80]</xref>. Further, Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), an international public-private partnership, has been established to co-ordinate and speed up the response to the COVID-19 pandemic. Government organisations (in the US and one in Europe), international biopharmaceutical companies and a non-profit organisation are all involved in advancing vaccine development 
 <xref rid="b0405" ref-type="bibr">[81]</xref>.
</p>
